Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01541306 · ClinicalTrials.gov registry record
C-Type Natriuretic Peptide and Achondroplasia
A clinical trial of Achondroplasia and Hypochondroplasia, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 91
- Enrollment target
- 1
- Study location
NCT01541306 is a study of Achondroplasia and Hypochondroplasia that has completed, run by Nemours Children's Clinic. The registered enrollment target is 91 participants, below the 141-participant average among 9 other Achondroplasia trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01541306, a study of Achondroplasia and Hypochondroplasia, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
Achondroplasia and hypochondroplasia are the most common forms of dwarfism. Recent studies have shown that a small hormone called C-type natriuretic peptide (CNP) is an important regulator of linear growth. The investigators believe that genetic abnormality that causes achondroplasia and hypochondroplasia also disrupts CNP signaling, which may contribute to the growth problem. The investigators propose to look at levels of this and other closely related hormones in children and adults with achondroplasia or hypochondroplasia to see if they are different from levels in healthy people. The investigators hypothesis is that CNP levels are elevated in children with achondroplasia or hypochondroplasia, compared the healthy population. Another hypothesis is that CNP levels are not elevated in adults with achondroplasia or hypochondroplasia, since adults have no growth-plate cartilage. By studying the potential role of the CNP system in achondroplasia and hypochondroplasia, not only will the investigators provide further insight into the pathophysiology of these common syndromes, the investigators will also provide greater insight into the regulation of normal linear growth.
Conditions Studied
Study Locations (1)
Delaware
- Alfred I. duPont Hospital for Children - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01541306
The ClinicalTrials.gov registry entry for NCT01541306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 9 other Achondroplasia trials with a reported enrollment target (35% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Achondroplasia appearing as the primary indexed condition, and to 0 interventions.
NCT01541306 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT01541306 about?
NCT01541306 is a clinical study titled "C-Type Natriuretic Peptide and Achondroplasia". Achondroplasia and hypochondroplasia are the most common forms of dwarfism. Recent studies have shown that a small hormone called C-type natriuretic peptide (CNP) is an important regulator of linear growth. The investigators believe that genetic abnormality that causes achondroplasia and hypochondro...
What is the current status of trial NCT01541306?
This trial is currently completed. The enrollment target is 91 participants. The study started on 2012-02. Estimated completion is 2014-12.
What conditions does trial NCT01541306 study?
This clinical trial studies the following conditions: Achondroplasia, Hypochondroplasia.
Who is sponsoring clinical trial NCT01541306?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01541306 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Achondroplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
RECRUITING · Phase 2
-
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
RECRUITING · Phase 2
-
VIrtual STudy in Achondroplasia for the US (VISTA)
RECRUITING
-
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
RECRUITING · Phase 2
-
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.